“
“Hemophilia A and hemophilia B are caused by congenital deficiency of factor VIII and factor IX, respectively, and may lead to recurrent, spontaneous bleeding into the muscles and joints resulting in disabling arthropathy. Effective management

is available in the form of prophylactic infusions of clotting factor concentrates which have been demonstrated to prevent bleeding Selleckchem DMXAA episodes and greatly improve the quality of life of these patients. Prophylaxis is, however, expensive. Usual dosing regimens rely on weight based calculations but dosing with an understanding of an individual’s pharmacokinetic response has been demonstrated to be more effective in predicting clotting factor levels that protect against bleeding episodes. Standard pharmacokinetic studies require a prohibitive number of time sampling points but recent population or Bayesian pharmacokinetics

can be used to provide an accurate estimation of an individual’s pharmacokinetic response using a limited number of sampling time points. The use of population pharmacokinetics has the potential to greatly selleck chemicals increase the use of pharmacokinetic dosing regimens and optimize the use of clotting factor concentrates in patients with hemophilia. Pediatr Blood Cancer 2012; 60: S27S29. (C) 2012 Wiley Periodicals, Inc.”
“We pattern submicrometer structures of thin films of permalloy in the form of two crossing ellipses and in the form of one long ellipse crossed by several ellipses where the width of the ellipses varies between 100 and 1000 nm. We find that the crossing area has two stable axes of magnetization, which are perpendicular to each other and which are rotated by 45 degrees relative to the axes of the ellipses. We measure the planar Hall effect (PHE) of AZD7762 the

submicrometer structures and demonstrate sharp switching behavior between the two easy axes of the magnetization. The observed behavior is modeled analytically with bi-axial magnetic anisotropy and compared with numerical simulations. We discuss possible application of such submicrometer structures for PHE-based magnetic memory. (C) 2012 American Institute of Physics. [doi:10.1063/1.3677885]“
“The prevalence of obesity in patients with haemophilia (PWH) is increasing. We investigated the effect of obesity on bleeding frequency and clotting factor concentrate (CFC) usage in PWH and assessed whether prothrombotic changes observed in obesity differ between controls and PWH. Number of bleeds and CFC usage were compared between obese (N=51) and non-obese (N=46) haemophilia A patients. Markers of haemostasis and fibrinolysis were compared between PWH, and gender-, age- and body mass index (BMI)-matched non-haemophilic controls (N=91). Median number of bleeds/patient-month was comparable between obese and non-obese patients with severe haemophilia (P=0.791). Obese patients with severe haemophilia used 1.4 times more CFC/patient-month than non-obese patients (P=0.036). When adjusting for weight this difference disappeared (P=0.451).